The genome of hepatitis B virus (HBV) encodes two transcriptional activators: the HBx protein and the PreS2-activator large surface protein (LHBs). Both proteins trigger activation of c-Raf-1/MEK kinase cascade. In case of HBx this can be mediated by a PKC-independent and Ras-dependent mechanism, in case of LHBs activation is PKC-dependent and does not require Ras. Selective destruction of either LHBs-or of HBx-specific activation does not result in significant decrease of viral production from transfected HepG2 cells. Simultaneous inhibition of LHBs-and HBx-dependent activation by blocking signaling steps common to both activators, using trans dominant negative c-Raf-1-or MEK-specific inhibitors, abolished HBV gene expression. In accordance with this no HBV propagation was observed after transfection of a mutated HBV genome defective for HBx-and PreS2-activator function. A detailed analysis revealed that the observed inhibition of HBV-propagation is because of a significant reduction of HBV-specific RNA resulting in an inhibition of the de novo synthesis of viral compounds (viral proteins and nucleic acid) and not by blocking secretion or assembly of the virus. Based on these results we conclude that transcriptional-activator function, mediated by the cRaf-1/MEK signaling cascade, is essential for HBV gene expression.
Introduction
Infection by hepatitis B virus (HBV) can cause an acute inflammation of the liver. In addition, HBV is a major causative agent for the development of hepatocellular carcinoma (HCC). In the light of this, many studies have focused on the identification of potential viral oncogenic products. With the discovery that HBV encodes at least two transcriptional activators, HBx (Twu and Schloemer, 1987; Wollersheim et al., 1989) and the PreS2 activators large surface protein/middle surface protein (LHBs/MHBs) (Kekule et al., 1990; Hildt et al., 1996) , attention focused on the identification of cellular targets which, upon activation, might lead to transformation of the infected cell (for reviews, see Hildt and Hofschneider, 1998; Andrisani and Barnabas, 1999) . The relevance of the activator function for the viral life cycle, however, remained more or less enigmatic. In the case of WHV, it was observed that the productive viral life cycle requires the presence of functional WHX protein (Zoulim et al., 1994) ; in the case of HBV the relevance of HBx for the viral life cycle is suggested (Bouchard et al., 2001) .
HBx is a 154 aa-sized activator, with an apparent molecular weight of about 17 kDa. A variety of different signal transduction pathways was described to be HBx-dependent activated. Mechanisms mediating HBxdependent activator function include the Ras-dependent activation of c-Raf-1/MEK/Erk2 and MEKK-1/JNK cascades, leading to the induction of several transcription factors, for example, AP-1 or NF-kB (Benn and Schneider, 1994; Su and Schneider, 1996; Klein and Schneider, 1997; Su et al., 2001) . A major pathway of HBx-dependent signaling is activation of Ras or further upstream of Src (Klein and Schneider, 1997; Klein et al., 1999) . Recently, activation of Pyk2 and subsequent activation of src by HBx was described (Bouchard et al., 2001) .
The sequence encoding for PreS2 activators is localized in the HBV surface gene. The surface gene is separated by three in frame ATG-codons in the preS1-, preS2-and S-region. The LHBs encompasses the Pres1-, PreS2-and S-domain, the (MHBs) PreS2-and S-domain and the small (SHBs) surface protein the S-domain. The activator function of surface protein requires integrity of the PreS2-domain and its cytoplasmic orientation as in the case of a fraction of LHBs (Bruss et al., 1994; Hildt et al., 1995 Hildt et al., , 1996 . The PreS2-domain binds to PKCa/b leading to a Ras-independent, PKC-dependent activation of the c-Raf-1/MEK signal transduction cascade .
In this study, the relevance of both activator functions for the viral life cycle were investigated. For this purpose HBx-or LHBs-dependent activation was selectively blocked or signaling was inhibited at steps common to both activators.
Results

Selective inhibition of HBx-or LHBs-dependent activator function does not affect HBV expression
Functionality of Ras is a prerequisite for HBx-dependent transcriptional activation (Benn and Schneider, 1994) , but not for LHBs-dependent activation . In contrast, LHBs triggers PKC-dependent activation of c-Raf-1/MEK-signal transduction cascade. Activation of liver-specific isoforms PKC a/b is the initial step for PreS2-dependent signal transduction (Hildt et al., 1996 , while inhibition of PKC does not affect HBx-dependent transcriptional activation (Lucito and Schneider, 1992; Murakami et al., 1994) . Inhibition of LHBs-dependent transcriptional activation was performed using cell permeable peptides (Oess and Hildt, 2000) as very specific inhibitors of PKC. To analyse the relevance of HBx-dependent transcriptional activation for HBV-expression Ras was inhibited by coexpression of a trans dominant negative (tdn) mutant (pRasN17) of Ras; relevance of LHBs-dependent activation was analysed using the PKC inhibiting cell permeable peptides. Functionality of these inhibitory molecules was controlled as described under Materials and methods. Cotransfection of HepG2 cells with HBVexpression plasmid pSPT1.2 and pRasN17 did not result in a significant reduction of HBsAg or HBeAg secretion as well as inhibition of PKC as compared to the control ( Figure 1a ). If pRasN17 was replaced by pHaRas (coding for a constitutive active Ras mutant) no significant increase in HBsAg/HBeAg production could be observed (Figure 1a ), indicating that Ras is not limiting for HBV replication. For a more detailed analysis the viral secretion was directly determined by quantification of viral DNA in the supernatant performing taqman PCR. No significant change of HBV-specific DNA content in the supernatant was revealed when Ras or PKC are inhibited (Figure 1b) . Western blot analysis of cellular lysates from pSPT1.2 transfected cells using a PreS1-specific antiserum revealed no significant change in the LHBs amount as compared to the control when Ras or PKC were inhibited (Figure 1c) . Inhibition of PKC using the commercial inhibitor Goe 6976 gave identical results.
These results indicate that selective inhibition of HBxor LHBs-dependent transcriptional activator function does not affect viral propagation.
Inhibition of c-Raf-1 blocks HBV gene expression
Activation of c-Raf-1/ MEK signal transduction cascade is common to HBx as well as to LHBs (Benn and Schneider, 1994; Hildt and Hofschneider, 1998; Andrisani and Barnabas, 1999) . In accordance with this, an activation of c-Raf-1/MEK can be observed in HBV-producing cells. (EH unpublished results) . To analyse the relevance of c-Raf-1/ MEK activation for viral replication, c-Raf-1 was inhibited by expression of a tdn mutant (RafC4). Functionality of this tdn mutant was controlled as described under Materials and methods. Cotransfection For inhibition of HBx-dependent activation pRasN17 was cotransfected encoding for trans dominant negative Ras. Inhibition of LHBs-dependent activation was performed using a PKC-specific cell permeable inhibitory peptide. The HBeAg/HBsAg values obtained from pSPT1.2 transfected cells were set at 100 and the other values were related to it. The experiments were performed in duplicate and reproduced three times. One representative experiment is shown. (b) Quantification of HBV-specific DNA in the supernatant from pSPT1.2-transfected HepG2 (see Figure 1a ) cells was determined by taqman PCR. Inhibition of HBx-or LHBs-dependent activator function was performed as described above. The DNA-content determined for pSPT1.2-transfected cells was set at 100 and the other values were related to it. The experiments were performed in duplicate and reproduced three times. One representative experiment is shown. (c) Western blot analysis of cellular lysates derived from pSPT1.2-transfected HepG2 cells (see Figure 1a) . Inhibition of HBx-or LHBs-dependent-activator function was performed as described above. For detection of LHBs the PreS1-specific antibody Ma18/7 was instrumental. The experiments were reproduced three times. One representative experiment is shown HBV replication requires c-Raf-1/MEK signaling L Stöckl et al of pSPT1.2 with pRafC4 caused a strong reduction of HBsAg/HBeAg secretion into the medium as compared to the control (Figure 2a ). To exclude that the observed effect is because of an unspecific effect of the tdn mutant, a very specific inhibitor (PD98059) that acts downstream from c-Raf-1 by inhibition of MEK was used. Here the structurally related SB202474, that displays no inhibitory function, served as control. Inhibition of MEK by PD98059 caused an identical reduction of HBsAg/HBeAg secretion ( Figure 2a ) as compared to inhibition of c-Raf-1 by the tdn mutant pRafC4. To analyse whether reduction of HBsAg/ HBeAg secretion is reflected by a decreased amount of viral particles in the medium, viral DNA was directly quantified by taqman PCR. A drastically diminished amount of virus-specific DNA after inhibition of c-Raf-1 or MEK was observed (Figure 2b ). This was further confirmed performing endogenous polymerase reaction (EPR): inhibition of c-Raf-1 resulted in a significant reduction of viral particle production ( Figure 2c ). Comparable results were obtained by simultaneous inhibition of HBx-and LHBs-dependent activation using tdn Ras N17-and PKC-inhibitory peptides (data not shown).
On the other hand, cotransfection of pSPT1.2 with pvRaf (encoding for constitutive active c-Raf-1) did not result in a significantly increased amount of virus-specific DNA or HBeAg/HBsAg in the supernatant (Figure 2a, b) .
These results indicate that functionality of c-Raf-1/ MEK signal transduction cascade is essential for the production of viral particles, but endogenous c-Raf-1 activity is not limiting for viral synthesis.
Functionality of c-Raf-1/MEK signal transduction cascade is essential for HBV gene expression
Based on the results described above, it remained unclear whether the observed tremendous reduction of MEK was blocked using inhibitor PD98059. SB202474 a chemically related, but inactive molecule served as control. Permanent activation of MEK was obtained by cotransfection of pv-Raf that encodes for a constitutive active form of c-Raf-1. The HBeAg/ HBsAg values obtained from pSPT1.2-transfected cells were set at 100 and the other values were related to it. The experiments were performed in duplicate and reproduced three times. One representative experiment is shown. (b) HBV-specific DNA in the supernatant from pSPT1.2-transfected HepG2 (see Figure 1a ) cells was quantified by taqman PCR. c-Raf-1 /MEK were inhibited as described above. For overexpression of constitutive active c-Raf-1 vector pv-Raf was instrumental. The DNA-content determined for pSPT1.2-transfected cells was set at 100 and the other values were related to it. The experiments were performed in duplicate and one representative experiment is shown. (c) Quantification of viral particles in the supernatant from pSPT1.2-transfected HepG2 (see Figure 1a ) cells was performed by EPR. Inhibition of c-Raf-1 was performed by cotransfection of pRafC4. The experiment was performed in duplicate; one representative experiment is shown HBV replication requires c-Raf-1/MEK signaling L Stöckl et al viral secretion is only because of a reduced de novo synthesis of viral compounds or due to a block in virus assembly/secretion. To investigate this problem HepG2.2.15 was treated with PD98059 to inhibit MEK and immunofluorescence microscopy using a PreS1-(LHBs) or HBcAg-specific antiserum was performed. As compared to the untreated control the LHBs-as well as the HBcAg-specific signal disappeared HBV replication requires c-Raf-1/MEK signaling L Stöckl et al ( Figure 3a ). This argues against accumulation of these viral compounds because of a block in assembly or secretion. By contrast these data suggest that by inhibition of both, PreS2-and HBx-dependent signal transduction, a strong reduction of the de novo synthesis of viral compounds occurs. This was confirmed by Western blot analysis of cellular lysates derived from pSPT1.2 transfected HepG2 cells cotransfected with pRafC4 or grown in the presence of increasing concentrations of PD98059 using a Pres1-or HBcAg-specific serum. The Western blots (Figure 3b, c) clearly show a strong reduction of LHBs and HBcAg production in response to c-Raf-1/MEK inhibition. To exclude any unspecific effect as a result of a reduced viability of the cells, XTTassays were performed (data not shown). Over the time period investigated in the experiments described above (40 h, max. 60 h) no significant change in the viability was observed.
Southern blot analysis of total intracellular viral DNA isolated from pSPT1.2-transfected cells revealed that cotransfection with pRafC4 caused a complete loss of HBV-specific 3.2 kB-sized DNA. This shows that under these conditions no accumulation of replicative intermediates occurs (Figure 3d) .
To reveal the mechanism that leads to the inhibition of de novo synthesis of the analysed viral proteins total RNA was isolated from transfected cells and reverse transcriptase-polymerase chain reaction (RT-PCR) was performed as described under Materials and methods. The RT-PCR using HBV-specific primer revealed that inhibition of c-Raf-1 by cotransfection with pRafC4 or inhibition of MEK by PD98059 caused a reduction of HBV-specific transcripts below the detection level (Figure 3e ). These data indicate that the inhibitory effect of pRafC4 or of the MEK inhibitor is because of a reduced amount of HBV-specific RNA.
These results indicate that functionality of the c-Raf-1/MEK signal transduction cascade triggered by the HBV activators LHBs and HBx is essential for the production of viral particles.
Functionality of the HBV-activator function is essential for HBV propagation
To investigate whether indeed the functionality of HBx and of the PreS2 activator are essential for HBV propagation three different 1.2-fold HBV constructs were generated: (i) a HBx-deficient construct, (ii) a PreS2-activator-deficient construct, and (iii) a double mutant lacking HBx-and PreS2-activator function. HBx was knocked out by the introduction of a stop codon. The PreS2-activator function was abolished by mutation of the phosphorylation site at aa 27-31. Integrity of the phosphorylation site is a prerequisite for the PreS2-dependent transcriptional activation .
Transfection of HepG2 cells with the HBx-deficient or the PreS2-activator-deficient construct resulted not in a significant change of HBsAg or HBeAg secretion as compared to the control, pSPT1.2-transfected cells. This was also confirmed by taqman PCR for quantification of the viral DNA in the supernatant.
In the case of the double mutant lacking the HBx and the PreS2 activator, a complete loss of HBsAg and HBeAg secretion was observed as well as a drastically diminished amount of virus-specific DNA in the supernatant as determined by taqman PCR (Figure 4) .
These results indicate that the transcriptional activator function is crucial for HBV propagation.
Discussion
The results described above demonstrate the relevance of the transcriptional-activator function for HBV gene expression. The importance of the activator protein function for the viral life cycle seems to be reflected by the fact that HBV possesses two activator proteins that are redundant in many functions. With respect to the activation of c-Raf-1/MEK signal transduction cascade LHBs and HBx can replace each other. Integrity of the c-Raf-1/MEK signal transduction cascade is a prerequisite for productive viral replication.
From the data presented here, it cannot be concluded that HBx generally is dispensable for the viral life cycle. A variety of reports describes an important role of HBx for the viral life cycle of HBV (Klein and Schneider, 1997; Bouchard and Schneider, 2001 ). In the case of WHV, the X protein was described as crucial for the viral life cycle (Zoulim et al., 1994) . While HBx and LHBs with respect to activation of c-Raf-1/MEK can replace each other, it remains open whether further HBx/LHBs-specific functions are essential for the establishment of a productive viral infection; that is, modulation of apoptotic mechanisms during the infection process (Su et al., 2001) .
Inhibition of viral replication by selective interference with signal transduction is not unprecedented; that is, a recent report described the dependency of influenza virus replication on functional MEK (Pleschka et al., 2001 ) and earlier reports described that efficient replication Figure 4 Knock out of HBx-and PreS2-activator function abolishes HBV propagation. HBV-specific DNA in the supernatant from transfected HepG2 cells was quantified by taqman PCR. Cells were transfected with the wild-type construct pSPT1.2, the HBxdeficient mutant pSPT1.2defX, the PreS2-activator-deficient mutant pSPT1.2defPreS2 or with the double mutant lacking HBx-and PreS2-activator function pSPT1.2defXdefPreS2. The DNA-content determined for pSPT1.2 transfected cells was set at 100 and the other values were related to it. The experiments were performed in triplicate and one representative experiment is shown HBV replication requires c-Raf-1/MEK signaling L Stöckl et al of HIV can be reduced by the inhibition of NF-kB activation (Schreck et al., 1992) . For DHBV, it was described that the activation of cAMP-dependent signal transduction cascades confers an inhibition of DHBV infection (Hild and Hofschneider, 1998) . Based on the results described above it is tempting to speculate whether inhibition of c-Raf-1/MEK could be a target for the future generation of antivirals: a fundamental intracellular signal transduction cascade would be affected. Inhibition of c-Raf-1/MEK over a longer time period, of course, finally would interfere with cell viability. HBx-and LHBs-dependent activation of cRaf-1/MEK must be inhibited or the application of cRaf-1/MEK/Erk2-inhibitory molecules has to be limited for a short time period and must be restricted to HBVinfected cells. Since the observed effects in this study were tremendous, in combination with other therapeutic strategies a shorter period could be sufficient to eliminate the virus. This hope is based on the observation that inhibition of c-Raf-1/MEK signaling cascade results in a reduction of viral RNA below the detection level leading to an overall block of viral protein and nucleic acid de novo synthesis. Therefore, no intracellular accumulation of replicative intermediates, with the risk of an elevated insertion frequency leading to chronicity and increased risk of HCC development has to be expected.
Materials and methods
Cell culture and transfection assays
HepG2 cells were cultured in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal calf serum. For expression of HBV plasmid pSPT1.2 (Weiss et al., 1996) was instrumental. To inhibit activity of c-Raf-1 the tdn mutant pRafC4 (Bruder et al., 1992) was used. For the inhibition of Ras the tdn mutant pRasN17 (kindly provided by W Fantl, San Francisco, USA) was instrumental. The functionality of pRasN17 was controlled by reporter gene assays (data not shown). Cotransfection of HepG2 cells with pRasN17, a HBxexpression plasmid (pCMVX) and an AP-1-dependent reporter construct (p-3xAP-1-CAT) abolished the HBx-dependent induction of AP-1 . The functionality of tpRafC4 was demonstrated by cotransfection of HepG2 cells with HBx-(pCMVX) or LHBs-(pSVLM-S-) expression plasmid with pRafC4 and an AP-1-dependent CAT-reporter gene (p3xAP-1CAT): HBx-as well as LHBs-dependent activation of AP-1 could be blocked by expression of trans dominant negative c-Raf-1 . Cells were transfected by lipofection using DOTAP (Roche). For transfections of 0.8 Â 10 6 cells 1 mg pSPT1.2 and 1 mg pCDNA.3 were used. In the case of cotransfection of pRasN17 or pRafC4 pCDNA.3 was replaced by these constructs. Transfection efficiency was determined by transfection of cells with peGFP (Clontech, Palo Alto, CA, USA). Transfection efficiency was at 50-60%. Determination of cell viability was performed by XTT-assays, indicating that over a time period of 60 h expression of tdn c-Raf-1 or presence of PD98059 does not reduce viability. After the expression of tdn-cRaf-1 or exposure to PD98059 longer than 85 h a beginning reduction of cell viability could be performed. As an additional control a bicistronic-expression plasmid encoding for 6H-tdn-c-Raf and eGFP was instrumental. Double fluorescence microscopy 40-60 h after transfection using a hexa-his-tag-specific antiserum for detection of tdn-c-Raf-1 revealed that eGFP and tdn-c-Raf-1 are simultaneously expressed, indicating that in this time period gene expression is not significantly affected by tdn c-Raf-1.
Construction of expression plasmids
Generation of the HBx-and/or PreS2-activator function deficient HBV-expression plasmids was based on the plasmid pSPT1.2 (Weiss et al., 1996) that harbors a 1.2-fold HBV genome subtype adr4. HBx was knocked out by the introduction of a stop codon. The PreS2-activator function was eliminated by the mutation of the phosphorylation site at Ser27-29 in the PreS2-domain. The following primers were instrumental. HBVnt1247-1230: GGGCCATGGAAAGGA-GGTGTATTT (A); HBVnt3152-3176mutP: GGGGATATC-GGCGGCGGTGCCGGAACAGTAAAC (B); H B V n t 1 2 4 4-1 2 6 7: CCCCCATGGCTGCTAGGGTGTGCTGCC (C); H B V n t-1244-1267stop: CCCCCATGGCTGCTT-GAGTGTGCTGCC (D) HBVnt3152-3128: GGGGATAT-CAGGAAAGTATAGGCCCCT(E) H B V n t 3 1 5 2 -3176 wt: GGGGATATCGGCTCCAGTTCCGGAACAGTAAAC (F). Plasmid pSPT1.2 served as template. For generation of Xdeficiency the primer combinations A/B and C/E were instrumental; for generation of the PreS2-activator deficiency the primer combinations A/B and C/E were used; for generation of the double mutant lacking HBx-and PreS2-activator function the primer pairs A/B and D/E were used. The PCR products were NcoI/EcoRV restricted and ligated.
Protein analysis
HBsAg and HBeAg were determined by commercially available ELISA systems (Dade Behring). Cell lysates were prepared as described recently (Hildt and Oess, 1999) . For Western blot analysis 30 mg total protein were used; proteins were separated by SDS-PAGE and transferred by semidryblotting onto PVDF membranes (Millipore, 0.45 mm). Probing was performed as described (Oess and Hildt, 2000) .
Indirect immunofluorescence labeling
HepG2.2.15 cells were seeded onto chamber slides. Cells were washed with PBS and fixed with ice-cold ethanol for 10 min. LHBs were detected using a mouse monoclonal anti-PreS1 MA18/07 (Heermann et al., 1984) HBcAg was detected using anti-HBcAg rabbit-derived serum (Chemicon). Bound antibodies were visualized by incubation with Cy2-(anti-mouse) or Cy3-(anti-rabbit) conjugated antibody (Dianova). Cells were analysed on a DMR fluorescence microscope (Leica). In order to exclude fixation artifacts integrity of fixed cells was confirmed by phase contrast microscopy of the same specimens.
PKC-inhibitory peptides -MEK inhibitors
Peptides were synthesized by a step-wise solid-phase peptide synthesis method and purified by C 18 reverse-phase HPLC. Molecular weights of purified peptides were verified by mass spectrometry. The sequence of the HBV-TLM-derived cell permeable peptides (Oess and Hildt, 2000) was PLSSIFS-RIGDPRFARKGALRNKNVHDVKN (wt peptide) or PLSSIFSRIGDPKKLAP (control peptide). The peptide was used in a final concentration of 2 mm and every 6 h added to the medium. The functionality of the peptide was tested under the same conditions by its capacity to inhibit either LHBsor PMA-dependent activation of a AP-1-dependent-driven reporter gene p3 Â AP-1-CAT or of c-Raf-1 . The MEK inhibitor PD98059 was present for 36 h before harvest of the cells in a concentration of 20 mm. SB202474 a related but infunctional substance served as control.
taqman PCR Viral particles were enriched from the supernatant by IP using a HBsAg-specific goat-derived serum (DAKO). To eliminate transfected DNA a DNase I treatment was performed. DNAse was destroyed by heating to 941C and removed by purification of the viral nucleic acid using a commercial kit (Roche, viral nucleic acid purification kit). For detection of virus-specific DNA forward primer binding to ntHBV184-203 and a backward primer binding to ntHBV 273-249 was instrumental. The probe corresponded to ntHBV218-247. The assay was calibrated in a range corresponding to 10 2 -10 9 copies of HBV genomes. The number of a genomes detected after transfection of cells with pSPT1.2 supernatant varied between 10 5 and 10 7 /ml.
RNA isolation and RT-PCR analyses
Total cellular RNA was prepared from 10 6 cells using Tritol reagent (Gibco BRL). For control that the equal amount of RNA was subjected to RT-PCR were verified by detection of the human G3PDH mRNA. All samples were treated with DNase (Sigma) to eliminate the DNA amplification. Total cellular RNA was retrotranscribed by Superscript (Gibco BRL) according to the instructions of the manufacturer. Reactions were stopped by heat inactivation for 5 min at 901C. Aliquots of the cDNA were then amplified in a DNA thermocycler for 30 cycles with 2 U of Ampli Taq DNA polymerase (Perkin-Elmer) and 2 pmol of both upstream and downstream primers in a volume of 50 ml. Each PCR cycle included a denaturation step (941C, 45 s), an annealing step (601C, 30 s) and an elongation step (721C, 30 s). The following primers were used for amplification:HBxfw: 5 0 -CTGGATCC-TGCGCGGGACGTCCTTT, HBxbw5 0 -GTGAAAAAGTT-GCATGGT, resulting in a 430-bp expected product; and G3PDHfw: 5 0 -ATGGCTAGCAAGAAAGTC,G3PDHbw; 5 0 TTGGGGGCAACTTGTGCCCT, resulting in a 212-bp product. PCR products were analysed on a 1.8% TAE agarose gel.
Immune precipitation and EPR
Cell culture supernatants were concentrated by Macrosep centrifugal concentrators 300 K (Pall Filtron), mixed with protein G agarose-(Roche) bound polyclonal HBsAg-antibody (DAKO) and precipitated for 16 h at 41C. The precipitate was incubated with 45 ml EPR buffer (50 mm Tris/HCl, pH 7.5; 50 mm NH 4 Cl; 5 mm MgCl 2 ; 0.3% 2-mercaptoethanol; 1% NP-40; 3.3 mm each dGTP, dATP and dTTP). After addition of 1 ml [ 32 P]-dCTP (6000 Ci/mmol, Amersham Pharmacia Biotech) the reaction mix was incubated at 301C overnight. Viral DNA was isolated by digestion with proteinase K (Sigma). DNA was separated on a 1% agarose gel and analysed by autoradiography.
DNA analysis from intracellular core particles
Cells lysed in 50 mm Tris, pH 7.4, 1 mm EDTA, 1% NP-40. The lysate was centrifuged at 10 000 g for 30 s at room temperature. After addition of CaCl 2 and MgCl 2 to a final concentration of 10 mmol/l each, the supernatant was incubated with 20 U/ml DNase I (Roche, Mannheim) for 2 h at 371C. Next, EDTA (final concentration, 20 mmol/l), 10% sodium dodecyl sulfate (SDS; final concentration 1%), and proteinase K (final concentration, 1 mg/ml; Promega) were added, followed by incubation for 12-16 h at 371C. Finally, phenol/chloroform extraction was performed and the DNA precipitated by isopropanol. Southern blotting was performed as described (Sambrook et al., 1989) and full-length HBV DNA was used as probe.
